These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 19278851

  • 1. Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.
    Ludwig H, Aapro M, Bokemeyer C, Macdonald K, Soubeyran P, Turner M, Albrecht T, Abraham I.
    Eur J Cancer; 2009 Jun; 45(9):1603-15. PubMed ID: 19278851
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years.
    Jacobs C, Frei D, Perkins AC.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii3-24. PubMed ID: 15824128
    [Abstract] [Full Text] [Related]

  • 4. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.
    Lawler EV, Gagnon DR, Fink J, Seliger S, Fonda J, Do TP, Gaziano JM, Bradbury BD.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2237-44. PubMed ID: 20083469
    [Abstract] [Full Text] [Related]

  • 5. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
    Wiecek A, Covic A, Locatelli F, Macdougall IC, ORAMA study group.
    Ren Fail; 2008 Jul; 30(3):267-76. PubMed ID: 18350446
    [Abstract] [Full Text] [Related]

  • 6. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
    Heras P, Kritikos K, Hatzopoulos A, Mitsibounas D.
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):619-23. PubMed ID: 18707619
    [Abstract] [Full Text] [Related]

  • 7. Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study.
    de Castro J, Ordóñez A, Isla D, Sánchez A, Arrivi A, Manzano JL, Barón MG.
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):35-42. PubMed ID: 16874498
    [Abstract] [Full Text] [Related]

  • 8. Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study.
    Aapro M, Ludwig H, Bokemeyer C, MacDonald K, Soubeyran P, Turner M, Albrecht T, Abraham I.
    Ann Oncol; 2009 Oct; 20(10):1714-21. PubMed ID: 19570966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results.
    Locatelli F, Covic A, Macdougall IC, Scherhag A, Wiecek A, ORAMA Study Group.
    J Nephrol; 2009 Oct; 22(5):662-74. PubMed ID: 19810000
    [Abstract] [Full Text] [Related]

  • 11. Management of anemia in advanced breast and lung cancer patients in daily practice: results of a French survey.
    Ray-Coquard I, Morère JF, Scotté F, Cals L, Antoine EC.
    Adv Ther; 2012 Feb; 29(2):124-33. PubMed ID: 22314432
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.
    Aapro MS, Link H.
    Oncologist; 2008 Feb; 13 Suppl 3():33-6. PubMed ID: 18458123
    [Abstract] [Full Text] [Related]

  • 14. [Comorbidity, anemia and response to erythropoiesis stimulating agents in chronic hemodialysis].
    Anaya S, Rivera F, Sánchez de la Nieta MD, Carreño A, Vozmediano C, Alcaide MP, Arambarri M, Nieto J, Caparrós G, Ferreras I.
    Nefrologia; 2008 Feb; 28(2):186-92. PubMed ID: 18454709
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study.
    de Castro J, Belda-Iniesta C, Isla D, Dómine M, Sánchez A, Batiste E, Barón MG.
    Lung Cancer; 2008 Feb; 59(2):211-8. PubMed ID: 17875340
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A.
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Haemoglobin fluctuations in patients on haemodialysis treated with ESAs: clinical observations from two centres.
    Roche A, Macdougall IC, Walker RG.
    Curr Med Res Opin; 2009 Dec; 25(12):2971-6. PubMed ID: 19842997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.